Helex logo

Helex

Genomic medicines for kidney diseases with high unmet need

33 employees · est. 2021 · New York, United States

VS
NephRx Corporation logo

NephRx Corporation

Pioneering treatments for kidney failure, renal disorders, and gastrointestinal diseases.

1 employees · est. 1995

NephRx Corporation is the older company (2021 vs 1995); Helex is the larger of the two.

Side-by-Side Comparison

Helex NephRx Corporation
Founded
2021 1995 older
Headquarters
New York, United States Not tracked yet
Employees
33 larger 1
Industry
Biotechnology, Clean Energy Biotechnology, Health Care, Health and Wellness
Funding Stage
Seed Series Unknown
Total Funding
$3.50M $6.22M
Funding Rounds
4 1
Services
development of genomic medicines, targeted drug delivery, gene therapy research, drug design using lipid nanoparticles, accelerating drug development Not tracked yet
Target Customers
patients with genetic kidney diseases, chronic kidney disease patients, biopharmaceutical companies, medical research institutions Not tracked yet
Taxonomy
Genomic Medicines, Kidney Diseases, Non-viral Delivery, Lipid Nanoparticle, Genome Editing, Renal Indications, Autosomal Dominant Polycystic Kidney Disease, Gene Editing, Epigenetics, Cell-specific Editing, Drug Design, Drug Discovery, Genomics Data, Bioinformatics, Data-driven Platform Therapeutic Products, Kidney Failure, Renal Disorders, Gastrointestinal Diseases, NX001, NX002, Transplant Patients, AMP-18, Drug Discovery, Acute Kidney Failure, Medical Research, Michigan, Biopharmaceuticals
Website
helex.bio nephrx.com
Helex logo

About Helex

Helex is making significant strides in the biotechnology arena by addressing the high unmet needs of kidney disease treatment. With its slogan, "Genomic medicines for kidney diseases with high unmet need," Helex aims to revolutionize the therapeutic landscape for renal conditions. Incorporated in 2...

NephRx Corporation logo

About NephRx Corporation

NephRx Corporation, established in 1995, is a biotechnology company with a focus on pioneering treatments for kidney failure, renal disorders, and gastrointestinal diseases. The company's offerings include NX001, which aids in the treatment of delayed graft function in kidney transplant patients, an...

We will tell you when either one moves

BounceWatch watches Helex and NephRx Corporation for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Helex and NephRx Corporation — by email.

Frequently Asked Questions

Helex — Genomic medicines for kidney diseases with high unmet need. NephRx Corporation — Pioneering treatments for kidney failure, renal disorders, and gastrointestinal diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Helex has raised $3.50M while NephRx Corporation has raised $6.22M.
Helex and NephRx Corporation operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Helex with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Helex on 26 Mar 2026, and NephRx Corporation on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy